G318

Insertion of non-biodegradable long-acting subcutaneous medication implant

Fee

ComponentValue
Provider fee$42.00
Schedule and sources
Fee edition
October 1, 2026
Record effective
2026-04-01
Schedule edition
July 22, 2026; effective July 1, 2026
Official files

PDF page 455 / J41

Insertion of non-biodegradable long-acting subcutaneous medication implant ............................................................. 42.00
Passages mentioning G318

PDF page 455 / J41

DIAGNOSTIC AND THERAPEUTIC PROCEDURES
 ENDOCRINOLOGY AND METABOLISM
                                                                                                Fee
+ G493 ACTH test - single or multiple, per injection ...........................                 6.25
+ G337 Antidiuretic hormone response test including the 8 hour water
         deprivation test ...................................................................   16.95
+ G338 Clonidine suppression test (for the investigation of
         pheochromocytoma) - with physician present - includes
         venipunctures .....................................................................    24.90
    Glucagon test
+ G494 - (Type A) for carbohydrate response ...................................                 10.20
+ G495 - (Type B) for hypertension, pheochromocytoma and
         insulinoma provocative test (including cold pressor test) ...                          42.30
  G358 Growth hormone exercise stimulation test with physician
          present (includes venipunctures) .......................................              24.90
+ G340 Histamine test to include a control cold pressor test ..............                     45.45
+ G341 Hypertonic saline infusion test ................................................         16.95
+ G497 Insulin hypoglycemia pituitary function test with or without TRH
          and LHRH alone or in combination ....................................                 49.80
+ G318 Insertion of non-biodegradable long-acting subcutaneous
          medication implant .............................................................      42.00
          Payment rules:
          1. G318 is not eligible for payment when provided by injection.
          2. G318 is only eligible for payment when the service is personally rendered by the physician
          [Commentary:
          1.Nexplanon is an example of non-biodegradable long-acting subcutaneous medication
            implant.
          2.Zoladex is an example of a biodegradable medication implant for which G318 is not eligible
            for payment.
          3.See Z114 and Z115 for removal of long-acting subcutaneous medication implant.
          4.For injections that do not meet the above criteria for G318, see Injections listings on page
            J54 of the Schedule.]
Diabetes monthly management
The provision to a patient, patient's relative(s), patient's representative or other caregiver(s) of medical
advice, direction or information by telephone or otherwise, in which a change in the frequency or dose
of insulin therapy is initiated regarding a patient treated with insulin injections (2 or more daily) or
insulin by pump (a "contact").
Fee master record

Master, record 2030. Record Layout PDF, page 1.

G31820260401999999990000042000000000000000000000000000000000000000000000000

Auxiliary master fields are preserved as raw scaled values. The linked layout calls them zero-filled, but this edition contains non-zero values. They are not presented as final dollar fees or PDF units.

FieldRaw / scale 10,000
provider00000420000 / 42
assistant00000000000 / 0
specialist00000000000 / 0
anaesthetist00000000000 / 0
non anaesthetist00000000000 / 0
Explanation

AI-generated. Unreviewed.

Insertion of a non-biodegradable long-acting subcutaneous medication implant, listed under the endocrinology and metabolism heading.

Watch out for

Not eligible for payment when provided by injection. Only eligible for payment when the service is personally rendered by the physician.

Sources and updates
Fee master effective October 1, 2026Schedule effective July 1, 2026Source versions and changes
Preparing offline search…